Correspondence 0001193125-23-008334 from BioAtla, Inc. (BCAB)
BioAtla, Inc.
Date: Jan. 13, 2023 · CIK: 0001826892 · Accession: 0001193125-23-008334
AI Filing Summary & Sentiment
File numbers found in text: 333-269148
Letter
11085 Torreyana Road
San Diego, CA 92121
January 13, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Arzhang Navai, Office of Life Sciences
Re:
BioAtla, Inc.
Registration Statement on Form S-3
Filed January 6, 2023
File No. 333-269148
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Acceleration Request
Requested Date:
January 17, 2023
Requested Time:
4:00 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioAtla, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-3 (File No. 333-269148) effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Company hereby authorizes Niki Fang, who is an attorney with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration.
The Company requests that it be notified of such effectiveness by a telephone call to Ms. Fang at (415) 773-5540.
[Signature page follows]
Sincerely,
BIOATLA, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP 11085 Torreyana Road San Diego, CA 92121 January 13, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Arzhang Navai, Office of Life Sciences Re: BioAtla, Inc. Registration Statement on Form S-3 Filed January 6, 2023 File No. 333-269148 REQUEST FOR ACCELERATION OF EFFECTIVENESS Acceleration Request Requested Date: January 17, 2023 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioAtla, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-3 (File No. 333-269148) effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable. The Company hereby authorizes Niki Fang, who is an attorney with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration. The Company requests that it be notified of such effectiveness by a telephone call to Ms. Fang at (415) 773-5540. [Signature page follows] Sincerely, BIOATLA, INC. By: /s/ Richard Waldron Name: Richard Waldron Title: Chief Financial Officer cc: Chris Vasquez, BioAtla, Inc. Niki Fang, Esq., Orrick, Herrington & Sutcliffe LLP